Celgene (CELG) on Watch Amid Takeover Chatter

September 22, 2016 10:34 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Celgene (NASDAQ: CELG) was in focus Thursday amid takeover chatter involving Novartis (NYSE: NVS).



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Rumors, Trader Talk

Add Your Comment